Exploiting tumor aneuploidy as a biomarker and therapeutic target in patients treated with immune checkpoint blockade
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2024-01-01
|
| Series: | npj Precision Oncology |
| Online Access: | https://doi.org/10.1038/s41698-023-00492-8 |